Effect of CL316,243, a highly specific β3-adrenoceptor agonist, on sympathetic nervous system activity in mice

Metabolism: Clinical and Experimental

Volumn 45, Issue 6, 1996, Pages 787-791

  Yoshida, Toshihide ^a   Umekawa, Tsunekazu ^b   Sakane, Naoki ^b   Yoshimoto, Kanji ^b   Kondo, Motoharu ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC TRANSMISSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CATECHOLAMINE METABOLISM; DRUG EFFECT; FEMALE; FOOD INTAKE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STATISTICAL ANALYSIS; THERMOGENESIS; URINARY EXCRETION;

EID: 0029933724     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90147-X     Document Type: Article

References (34)

1. 3 adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
2. Arch JRS, Ainsworth AT, Cawthorne MA, et al: Atypical β-adrenoceptor on brown adipocytes as target for antiobesity drugs. Nature 309:163-165, 1984
3. 3 adrenoceptor agonist, in mice with monosodium-L-glutamate-induced obesity. Eur J Endocrinol 131:97-102, 1994
4. Arch JRS, Cawthorne MA, Coney KA, et al: β-Adrenoceptor-mediated control of thermogenesis, body composition and glucose homeostasis, in Rothwell NJ, Stock MV (eds): Obesity and Cachexia. Chichester, UK Wiley, 1991, pp 241-268
5. Holloway BR: Selective β-agonist of brown fat and thermogenesis, in Lardy HA, Statman FW (eds): Hormones, Thermogenesis and Obesity. New York, NY, Elsevier, 1989, pp 477-484
6. Meier MK, Blum-Kaelin D, Gerold M, et al: Ro40-2148, a novel thermogenic β-agonist with anti-obesity activity, in Bjorntorp P, Rossner S (eds): Obesity in Europe 88. London, UK, Libbey, 1989, pp 329-338
7. Young JB, Landsberg L: Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269:615-617, 1977
8. Yoshida T, Kemnitz J, Bray GA: Lateral hypothalamic lesions and norepinephrine turnover in rats. J Clin Invest 72:919-927, 1983
9. Foster DO: Quantitative role of brown adipose tissue in thermogenesis, in Trayhurn P, Nicholls DG (eds): Brown Adipose Tissue. London, UK, Arnold, 1986, pp 31-51
10. Himms-Hagen J: Neural control of brown adipose tissue thermogenesis, hypertrophy and atrophy. Front Neuroendocrinol 12:38-93, 1991
11. 3-adrenoceptor agonist, in yellow KK mice. Life Sci 54:491-498, 1994
12. 3-receptors. A promising antidiabetic and antiobesity agent. J Med Chem 35:3081-3084, 1992
13. Vander Tuig JG, Ohshima K, Yoshida T, et al: Adrenalectomy increases norepinephrine turnover in brown adipose tissue of obese (ob/ob) mice. Life Sci 34:1423-1432, 1984
14. Yoshida T, Nishioka H, Nakamura Y, et al: Reduced norepinephrine turnover in mice with monosodium glutamate-induced obesity. Metabolism 33:1060-1063, 1984
15. Yoshimoto K, Komura S: Reexamination of the relationship between alcohol preference and brain monoamines in inbred strains of mice including senescence-accelerated mice. Pharmacol Biochem Behav 27:317-322, 1987
16. Yoshimoto K, Komura S, Kawamura K: Occurrence in vivo of 5-hydroxytryptophol in the brain of rats treated with ethanol. Alcohol Alcohol 27:131-136, 1992
17. Zar JH: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1974
18. 3-adrenoceptor agonist (CL316,243). Drug Dev Res 32:69-76, 1994
19. 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 266:R1371-R1382, 1994
20. Yen TT, Fuller RW, Hemrick-Luecke SK, et al: Effects of LY104119, a thermogenic weight-reducing compound, on norepinephrine concentrations and turnover in obese and lean mice. Int J Obes 12:59-67, 1988
21. 3-adrenergic receptor expression via cAMP response elements. Proc Natl Acad Sci USA 89:4490-4494, 1992
22. 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 43:548-555, 1993
23. 2 adrenergic receptor. Proc Natl Acad Sci USA 90:3665-3669, 1993
24. 2 adrenergic receptors in Chinese hamster fibroblasts. Mol Pharmacol 41:542-548, 1992
25. Carpene C, Galitzky J, Collon P, et al: Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J Pharmacol Exp Ther 265:237-247, 1993
26. 3-adrenoceptor messenger ribonucleic acids in adipose tissues. Endocrinology 130:109-114, 1992
27. Granneman JG: Effects of agonist exposure on the coupling of beta1- and beta3-adrenergic receptors to adenyl cyclase in isolated adipocytes. J Pharmacol Exp Ther 261:638-642, 1992
28. Benovic JL, Bouvier M, Caron MG, et al: Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol 4:405-427, 1988
29. Dohlman HG, Thorner J, Caron MG, et al: Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60:653-688, 1991
30. 3-adrenergic receptor: Relationship with the atypical receptor of adipocytes. EMBO J 10:3721-3727, 1991
31. +, K-ATPase and norepinephrine turnover in brown adipose tissue of obese (ob/ob) mice. Metabolism 33:652-657, 1984
32. Tedesco JL, Flattery KV, Sellers EA: Effects of thyroid hormones and cold exposure on turnover of norepinephrine in cardiac and skeletal muscle. Can J Physiol Pharmacol 55:515-522, 1977
33. Sellers EA, Flattery KV, Steiner G: Cold acclimation of hypothyroid rats. Am J Physiol 226:290-294, 1974
34. Tu T, Nash CW: The influence of prolonged hyper- and hypothyroid states on the noradrenaline content of rat tissues and on the accumulation and efflux rates of tritiated noradrenaline. Can J Physiol Pharmacol 53:74-80, 1975